NO310498B1 - Fremgangsmåte for fremstilling av et immunstimuleringsmiddel - Google Patents

Fremgangsmåte for fremstilling av et immunstimuleringsmiddel Download PDF

Info

Publication number
NO310498B1
NO310498B1 NO19905228A NO905228A NO310498B1 NO 310498 B1 NO310498 B1 NO 310498B1 NO 19905228 A NO19905228 A NO 19905228A NO 905228 A NO905228 A NO 905228A NO 310498 B1 NO310498 B1 NO 310498B1
Authority
NO
Norway
Prior art keywords
lysozyme
immunostimulant
bulgaricus
culture
milk
Prior art date
Application number
NO19905228A
Other languages
English (en)
Norwegian (no)
Other versions
NO905228L (no
NO905228D0 (no
Inventor
Harriet Link
Jean-Jacques Pahud
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4276966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO310498(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO905228D0 publication Critical patent/NO905228D0/no
Publication of NO905228L publication Critical patent/NO905228L/no
Publication of NO310498B1 publication Critical patent/NO310498B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO19905228A 1989-12-13 1990-12-03 Fremgangsmåte for fremstilling av et immunstimuleringsmiddel NO310498B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4484/89A CH680192A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1989-12-13 1989-12-13

Publications (3)

Publication Number Publication Date
NO905228D0 NO905228D0 (no) 1990-12-03
NO905228L NO905228L (no) 1991-06-14
NO310498B1 true NO310498B1 (no) 2001-07-16

Family

ID=4276966

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19905228A NO310498B1 (no) 1989-12-13 1990-12-03 Fremgangsmåte for fremstilling av et immunstimuleringsmiddel

Country Status (17)

Country Link
US (1) US5185321A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0432490B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2595133B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE127023T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU643728B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2030951C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH680192A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69022005T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0432490T4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2076280T5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3017428T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE68244B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MX172984B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO310498B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ236295A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT96167B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA909658B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994018997A1 (en) * 1993-02-24 1994-09-01 Valio Ltd. Method of enhancing immune response to oral vaccines
WO1994022459A1 (en) * 1993-04-07 1994-10-13 Eisai Co., Ltd. Immunopotentiative and infection-protective agent, containing two or more bacillus, egg white and garlic
US6348346B1 (en) 1994-05-27 2002-02-19 University Of Kentucky Research Foundation Method of inhibiting binding activity of immunoglobulins
DE19619505C2 (de) * 1996-05-14 1998-03-26 Zyma Gmbh Milch/Bakterienlysat zur Herstellung von Kosmetika und Arzneimitteln
GB9822619D0 (en) * 1998-10-19 1998-12-09 Porter William L Immune response stimulation
US6641808B1 (en) 1999-09-22 2003-11-04 Lacpro Industries, Llc Composition for treatment of obesity
US20040166101A1 (en) * 1999-09-22 2004-08-26 Bojrab Gregory G. Enchanced composition for treatment of gastrointestinal disorders and hyperlipidemia
US6696057B1 (en) 1999-09-22 2004-02-24 Lacpro Industries, Inc. Composition and method for treatment of gastrointestinal disorders and hyperlipidemia
US6827940B1 (en) 2000-05-25 2004-12-07 Aidan Products, Llc Immune-stimulating bacterial cell wall extracts
KR20030016298A (ko) * 2000-06-19 2003-02-26 칸디백스 프로프라이어터리 리미티드 칸디다증의 치료를 위한 조성물 및 방법
GB0027761D0 (en) * 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
US20040258779A1 (en) * 2003-06-06 2004-12-23 Pinegrin Boris V. Dietary and pharmaceutical compositions for treatment of anemia, thrombocytopenia, and leukopenia
JP4716770B2 (ja) * 2005-03-29 2011-07-06 キユーピー株式会社 免疫賦活・アレルギー改善剤の製造方法
JP4716769B2 (ja) * 2005-03-29 2011-07-06 キユーピー株式会社 血圧降下剤の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO134752C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1965-06-01 1976-12-08 Texim Entreprise Economique D
SU618088A1 (ru) * 1975-06-03 1978-08-05 Киргизский Научно-Исследовательский Институт Акушерства И Педиатрии Способ получени детского лечебного кисломолочного продукта
FR2343484A1 (fr) * 1976-03-10 1977-10-07 Anvar Le 2- (2-acetamido-2-deoxy-3-o-d-glucopyranosyl) -d-propionyl-l-alanyl-d- (a-methylamide)-glutamique et medicaments le contenant
SU789096A1 (ru) * 1978-03-23 1980-12-23 Киргизский Научно-Исследовательский Институт Акушерства И Педиатрии Способ получени кисломолочного продукта дл детского питани
JPS5553298A (en) * 1978-10-17 1980-04-18 Dainippon Pharmaceut Co Ltd Water-soluble peptide glycan
FR2454302A1 (fr) * 1979-04-18 1980-11-14 Rhone Poulenc Ind Nouvelle substance biologiquement active, sa preparation et les medicaments qui la contiennent
JPS58126797A (ja) * 1982-01-22 1983-07-28 Dainippon Pharmaceut Co Ltd ジサツカライドトリペプチド及びジサツカライドテトラペプチドの製法
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
SU1465003A1 (ru) † 1987-06-25 1989-03-15 Всесоюзный научно-исследовательский и конструкторский институт молочной промышленности Способ производства адаптированного кисломолочного продукта дл детского питани

Also Published As

Publication number Publication date
JP2595133B2 (ja) 1997-03-26
EP0432490A3 (en) 1991-08-21
ES2076280T5 (es) 2001-09-01
EP0432490A2 (fr) 1991-06-19
GR3017428T3 (en) 1995-12-31
ES2076280T3 (es) 1995-11-01
PT96167A (pt) 1991-09-30
DE69022005D1 (de) 1995-10-05
AU643728B2 (en) 1993-11-25
JPH03255034A (ja) 1991-11-13
NZ236295A (en) 1993-04-28
CH680192A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1992-07-15
IE68244B1 (en) 1996-06-12
DK0432490T3 (da) 1995-12-27
AU6702190A (en) 1991-06-20
ATE127023T1 (de) 1995-09-15
EP0432490B1 (fr) 1995-08-30
US5185321A (en) 1993-02-09
IE904323A1 (en) 1991-06-19
DK0432490T4 (da) 2001-08-06
PT96167B (pt) 2001-05-31
DE69022005T2 (de) 1996-02-15
NO905228L (no) 1991-06-14
DE69022005T3 (de) 2001-10-04
EP0432490B2 (fr) 2001-05-16
MX172984B (es) 1994-01-26
NO905228D0 (no) 1990-12-03
ZA909658B (en) 1991-09-25
CA2030951A1 (en) 1991-06-14
CA2030951C (en) 2002-01-15

Similar Documents

Publication Publication Date Title
Jedrychowski Reduction of the antigenicity of whey proteins by lactic acid fermentation
US5185321A (en) Process for producing immunostimulants
Adams et al. Heat resistant bacterial lipases and ultra-high temperature sterilization of dairy products
Brown et al. CAMP factor of group B streptococci: production, assay, and neutralization by sera from immunized rabbits and experimentally infected cows
RO109819B1 (ro) Metoda pentru obtinerea unui vaccin anti ecoli enterotoxigena
KR100366302B1 (ko) 항 헬리코박터 필로리 항체를 함유한 난황액을 이용한발효유 제조 방법
Shah et al. Food consistency effects of quarg in lactose malabsorption
Janney et al. Cold hemagglutinin cross-reactivity with Mycoplasma pneumoniae
RU2092068C1 (ru) Способ получения кисломолочного продукта
Kizer et al. Stimulation of lactic acid bacteria by substances concomitant to certain proteolytic enzymes
Thunell et al. Defined strains and phage-insensitive mutants for commercial manufacture of cottage cheese and cultured buttermilk
RU2177691C2 (ru) Способ производства кисломолочного продукта
JP7544461B2 (ja) ビフィズス菌生残性向上用組成物
Stickel et al. Peptic and tryptic digestion products as inexpensive culture mediums for routine bacteriologic work
Thorns et al. Studies on the effect of growth medium composition on the antigenicity of Mycoplasma bovis
US6348346B1 (en) Method of inhibiting binding activity of immunoglobulins
RU2127061C1 (ru) Способ производства кисломолочного напитка
Leijh et al. Extracellular stimulation by serum proteins required for maximal intracellular killing of microorganisms by mouse peritoneal macrophages
US3891751A (en) Vaccines and processes for their preparation
Meena et al. Effect of Lactobacillus helveticus and Dahi on β-Glucuronidase and β-Galactosidase Enzyme Activities in Mice against Infection of Salmonella enteritidis
CN109475585A (zh) 用于抑制因抗流感药引起的获得性免疫功能降低的组合物及其制造方法
SU1668390A1 (ru) Штамм бактерий VIвRIо NaG серовара 078, используемый дл изготовлени диагностической сыворотки
RU2208320C1 (ru) Способ приготовления производственной антагонистической закваски для сыров с низкой температурой второго нагревания
SU1668387A1 (ru) Штамм бактерий VIвRIо NaG серовара 079, используемый дл приготовлени моноварной диагностической сыворотки
GEETHA jfttatfter of beterinarp detente

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2003